Carcinosarcoma of Uterus
1 clinical trials · Condition
◉ Watch Carcinosarcoma of Uterus
| Record | Firm | Date |
|---|---|---|
| Cabozantinib Plus Nivolumab and Ipilimumab in Women With Recurrent Gynecologic Carcinosarcoma (NCT04149275) | University of Alabama at Birmingham | 2021-02-01 |
Track Carcinosarcoma of Uterus automatically
Every clearance here is in the API, with alerts when new ones post.